To: phbolton who wrote (46803 ) 6/25/1999 4:09:00 PM From: Thomas G. Busillo Read Replies (2) | Respond to of 53903
ph, the funniest number is the one that isn't there. Furthermore, Micron's balance sheet is strong and cash rich, totaling approximately $1.66 billion, including the Intel investment, which should enable the company to continue its conversions to 0.18-micron at an aggressive pace and further increase marhet share, while distancing itself from the competition. Where's the cash/share number? You know, the one that went from roughly $8.00 to roughly $6.50 then back up to roughly $8.00 despite that fact that it was based each time on the "$1.8 billion" figure? Don't tell me Gruntal just punted on the thing. C'mon, Gruntal, you were so close. Don't give up now on that cash-per-share ratio. Maybe you just need a little hint. Alright, let's do it. Got your pencils out? Good. Here we go: It's C-A-S-H PER S-H-A-R-E . No, you can't make that stuff up, which is why I say again, anyway who wants to can sign up for Multex and see it for themselves. Bloomberg needs to change the way they coverage ratings. In general, the financial media needs to change the way they cover analysts. Somewhere out there some analysts had to have come up with something a littel more realistic, but what does the financial media give us? What was yesterday's coverage? Gruntal/Eraiba - STRONG BUY Paine Webber/Lazlo - BUY DLJ/Boucher - BUY downed to Mkt. perform BBRS/Niles - L-T ATTRACTIVE (yeah, whatever) Merill/Osha - L-T ATTRACTIVE Why? Because Gruntal lowered their price target and estimates. Lazlo lowered his estimates. Boucher lowers his rating. Niles...I don't know. Does he even count since he had to release his own PR? Osha, of the 5, IMHO, he's alright. Unfortunately, he's at Merrill <g> What about the people who got it right? For example, John Joseph, who to be honest, I wasn't a big fan of when he was at Monty (I think that had more to do with my impression of Monty) - this guy nailed the top way back in Feb., had the thing at a nuetral ever since, and was looking for -0.08, and in terms of qualitative analysis, the stuff I've seen from him in the short time he's been at Salomon has been IHMO 1st rate. (Salomon is also offering a trial through Multex, so anyone can judge for themselves). But what happens? He gets no coverage for being right! Somewhere out there have to be other analysts in the same boat. Using the "sports-fan" analogy - that sucks. It's like writing up a ballgame and ignoring the guys who went 2-5, knocked in a few runs, turned a key double play and instead giving the ink to the guys who struck out with runners in scoring position and made a 2-run error. Good trading, Tom